GPR15 and malignant colon neoplasm: Our immune analysis in the secondary lymphoid organs thus reveal systemic, tumor-favoring immune signatures in Gpr15-KO mice that reflect the changes in the ‘local’ colon tumor immune environment (e.g., increased MDSC, CD4+ T cell subsets) and highlight an important role for GPR15-mediated immune mechanisms in colon cancer development.